Related Experiment Video
Updated: May 23, 2026

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
Notch2 activation by benzyl isothiocyanate impedes its inhibitory effect on breast cancer cell migration
Su-Hyeong Kim1, Anuradha Sehrawat, Shivendra V Singh
1Department of Pharmacology & Chemical Biology, University of Pittsburgh Cancer Institute, University of Pittsburgh School of Medicine, 2.32A Hillman Cancer Center Research Pavilion, 5117 Centre Avenue, Pittsburgh, PA 15213, USA.
Abstract:
Benzyl isothiocyanate (BITC) is a promising anticancer constituent of edible cruciferous vegetables with in vivo efficacy against chemically induced as well as oncogene-driven breast cancer in experimental rodents. However, the mechanism underlying anticancer effect of BITC is not fully understood. This study was undertaken to determine the role of Notch signaling in anticancer responses to BITC as this pathway is often hyperactive in human breast cancer. Exposure of MCF-7, MDA-MB-231, and SUM159 human breast cancer cells to pharmacologic concentrations of BITC (2.5 and 5 microM) resulted in cleavage (activation) of Notch1, Notch2, and Notch4, which was accompanied by induction of γ-secretase complex components Presenilin1 and/or Nicastrin. The BITC-mediated cleavage of Notch was associated with its transcriptional activation as revealed by RBP-Jk and Hes-1A/B luciferase reporter assays. Inhibition of cell migration or cell viability resulting from BITC exposure was not influenced by pharmacological suppression of Notch1 using a γ-secretase inhibitor or RNA interference of Notch1 as well as Notch4. On the other hand, the BITC-mediated inhibition of cell migration, but not cell viability, was significantly augmented by siRNA and shRNA knockdown of Notch2 protein. Furthermore, the BITC-mediated inhibition of MDA-MB-231 xenograft growth in vivo was associated with a significant increase in nuclear levels of cleaved Notch2 and Hes-1 proteins. In conclusion, the results of this study indicate that (a) BITC treatment activates Notch2 in cultured and xenografted human breast cancer cells, and (b) Notch2 activation impedes inhibitory effect of BITC on cell migration.
Insights
Benzyl isothiocyanate (BITC) activates Notch2 signaling in breast cancer cells, hindering its own migration-inhibiting effects. This finding clarifies BITC
Area of Science:
- Oncology
- Molecular Biology
- Cancer Signaling Pathways
Background:
- Benzyl isothiocyanate (BITC) shows anticancer potential against breast cancer.
- The precise mechanisms of BITC's anticancer effects, particularly involving Notch signaling, remain unclear.
- Notch signaling is frequently dysregulated in human breast cancer.
Purpose of the Study:
- To investigate the role of Notch signaling in the anticancer responses to BITC.
- To determine how BITC affects Notch pathway activation in breast cancer cells.
- To elucidate the specific Notch receptors involved in BITC's effects on cell migration and viability.
Main Methods:
- Treatment of human breast cancer cell lines (MCF-7, MDA-MB-231, SUM159) with BITC.
- Assessment of Notch receptor cleavage and activation using Western blotting and luciferase reporter assays.
- Inhibition of Notch signaling via γ-secretase inhibitors and RNA interference (siRNA, shRNA).
- In vivo studies using MDA-MB-231 xenografts in rodents.
Main Results:
- BITC induced cleavage and activation of Notch1, Notch2, and Notch4 in breast cancer cells.
- BITC-mediated inhibition of cell migration was enhanced by Notch2 knockdown, but not Notch1 or Notch4.
- BITC treatment increased cleaved Notch2 and Hes-1 protein levels in xenograft tumors.
- Notch2 activation was found to impede the inhibitory effect of BITC on cell migration.
Conclusions:
- BITC activates Notch2 signaling in both cultured and xenografted human breast cancer cells.
- Notch2 activation by BITC counteracts BITC's inhibitory effects on cancer cell migration.
- Understanding this interaction is crucial for developing effective BITC-based cancer therapies.
Related Concept Videos
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Inhibition of Cdk Activity
Inhibition of CDK Activity
Chemotaxis and Direction of Cell Migration

